Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Page 1
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
CONCLUSIONS: I-CARE is an ongoing investigator-initiated observational European prospective cohort study that will provide unique information on the long-term benefits and risks of biological therapies in IBD patients. ...
CONCLUSIONS: I-CARE is an ongoing investigator-initiated observational European prospective cohort study that will provide unique informatio …
Incident Colorectal Cancer in Inflammatory Bowel Disease.
Neri B, Scribano ML, Armuzzi A, Castiglione F, D'Incà R, Orlando A, Festa S, Riegler G, Fries W, Meucci G, Alvisi P, Mocciaro F, Papi C, Mossa M, Sena G, Guidi L, Testa A, Renna S, Frankovic I, Viola A, Patturelli M, Chiaramonte C, Biancone L, On Behalf Of Ig-Ibd Italian Group For The Study Of Inflammatory Bowel Disease. Neri B, et al. Among authors: riegler g. Cancers (Basel). 2022 Jan 30;14(3):721. doi: 10.3390/cancers14030721. Cancers (Basel). 2022. PMID: 35158989 Free PMC article.
The open issues include the role of the characteristics of IBD and CRC in determining the long-term outcome. These issues were assessed in our multicenter study, including a cohort of 56 IBD patients with incident CRC. ...
The open issues include the role of the characteristics of IBD and CRC in determining the long-term outcome. These issues were assess …
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
Bossa F, Biscaglia G, Valvano MR, Costantino G, Lauria A, Clemente R, Ferracane C, Shahini E, Mendolaro M, Grossi L, Mazzuoli S, Rispo A, Pranzo G, Sebkova L, Tursi A, Miranda A, Patturelli M, Spagnuolo R, Ricciardelli C, Sgarro C, Paese P, Inserra G, Azzarone A, Nardone O, Fries W, Buccianti N, Privitera AC, Principi MB, Cappello M, Guglielmi FW, Romano M, Riegler G, Fanigliulo L, Melina R, Andriulli A. Bossa F, et al. Among authors: riegler g. Dig Dis Sci. 2020 Jun;65(6):1767-1776. doi: 10.1007/s10620-019-05904-z. Epub 2019 Nov 13. Dig Dis Sci. 2020. PMID: 31722059
BACKGROUND: Golimumab is a new anti-TNF-alpha monoclonal antibody for patients with ulcerative colitis. AIMS: To assess the short- and long-term effectiveness and safety of golimumab in daily clinical practice and to identify predictors of response. ...CONCLUSIONS: The eff …
BACKGROUND: Golimumab is a new anti-TNF-alpha monoclonal antibody for patients with ulcerative colitis. AIMS: To assess the short- and long- …
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S; ADMIRE CD Study Group Collaborators. Panés J, et al. Gastroenterology. 2018 Apr;154(5):1334-1342.e4. doi: 10.1053/j.gastro.2017.12.020. Epub 2017 Dec 24. Gastroenterology. 2018. PMID: 29277560 Clinical Trial.
BACKGROUND & AIMS: Therapies for perianal fistulas in patients with Crohn's disease are often ineffective in producing long-term healing. We performed a randomized placebo-controlled trial to determine the long-term efficacy and safety of a single local administ …
BACKGROUND & AIMS: Therapies for perianal fistulas in patients with Crohn's disease are often ineffective in producing long-term …
Pathophysiology of non-celiac gluten sensitivity: where are we now?
Caio G, Riegler G, Patturelli M, Facchiano A, DE Magistris L, Sapone A. Caio G, et al. Among authors: riegler g. Minerva Gastroenterol Dietol. 2017 Mar;63(1):16-21. doi: 10.23736/S1121-421X.16.02346-1. Epub 2016 Nov 3. Minerva Gastroenterol Dietol. 2017. PMID: 27808487 Review.
Non-celiac gluten sensitivity (NCGS) is the term used to describe individuals complaining of intestinal and extra-intestinal symptoms related to gluten ingestion and rapidly improving after its withdrawal, and in which both celiac disease (CD) and wheat allergy (WA) were p …
Non-celiac gluten sensitivity (NCGS) is the term used to describe individuals complaining of intestinal and extra-intestinal symptoms …
Musculoskeletal imaging in preventive medicine.
Kainberger F, Falkowski AL, Hirtler L, Riegler G, Schlegl T, Thaker S, Patsch J, Crevenna R. Kainberger F, et al. Among authors: riegler g. Wien Med Wochenschr. 2016 Feb;166(1-2):9-14. doi: 10.1007/s10354-016-0431-8. Epub 2016 Jan 27. Wien Med Wochenschr. 2016. PMID: 26819215 Review.
The added value provided by preventive imaging is (1) to monitor bone health and body composition with a broad spectrum of biomarkers, (2) to detect and quantify variants or abnormalities of nerves, muscles, tendons, bones, and joints with a risk of overuse, rupture, or fracture, …
The added value provided by preventive imaging is (1) to monitor bone health and body composition with a broad spectrum of biomarkers, (2) t …
Gallstone ileus without bilioenteric fistula years after bypass surgery for Crohn's disease. Case report and clues to etiology of a neglected cause of obstruction.
Pellino G, Candilio G, De Fatico GS, Marcellinaro R, Formicola GC, Volpicelli A, Sciaudone G, Riegler G, Canonico S, Selvaggi F. Pellino G, et al. Among authors: riegler g. Int J Surg Case Rep. 2015;9:134-8. doi: 10.1016/j.ijscr.2015.03.004. Epub 2015 Mar 7. Int J Surg Case Rep. 2015. PMID: 25770438 Free PMC article. Retracted.
Early suspect and diagnosis may allow for less aggressive approaches. A diverted segment should always be removed, and long-term follow-up encouraged....
Early suspect and diagnosis may allow for less aggressive approaches. A diverted segment should always be removed, and long-term foll …
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
Monterubbianesi R, Aratari A, Armuzzi A, Daperno M, Biancone L, Cappello M, Annese V, Riegler G, Orlando A, Viscido A, Meucci G, Gasbarrini A, Guidi L, Lavagna A, Sostegni R, Onali S, Papi C, Kohn A; Italian Group for the study of Inflammatory Bowel Disease (IG-IBD). Monterubbianesi R, et al. Among authors: riegler g. J Crohns Colitis. 2014 Aug;8(8):852-8. doi: 10.1016/j.crohns.2014.01.006. Epub 2014 Jan 25. J Crohns Colitis. 2014. PMID: 24472490
BACKGROUND: Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and the long term benefits are not well defined. The aim of the present study was to evaluate short- and long-term colectomy rate i …
BACKGROUND: Infliximab is effective as rescue therapy in severe corticosteroid-refractory ulcerative colitis. The optimal dose regimen and t …
Infliximab in drug-naïve patients with failed ileorectal anastomosis for Crohn's disease: a new chance for sparing the rectum?
Sciaudone G, Pellino G, Riegler G, Selvaggi F. Sciaudone G, et al. Among authors: riegler g. Eur Surg Res. 2011;46(4):163-8. doi: 10.1159/000324398. Epub 2011 Mar 31. Eur Surg Res. 2011. PMID: 21454983
The aim of this intervention study is to determine whether long-term infliximab therapy can decrease the proctectomy rate in patients with failed total colectomy and ileorectal anastomosis (IRA) for Crohn's disease (CD). ...
The aim of this intervention study is to determine whether long-term infliximab therapy can decrease the proctectomy rate in patients …
19 results